KPC Pharmaceuticals Inc  

(Public, SHA:600422)   Watch this stock  
Find more results for 600422
+0.31 (0.96%)
Dec 1 - Close
SHA data delayed by 1 mins - Disclaimer
Currency in CNY
Range 31.80 - 32.92
52 week 23.71 - 51.50
Open 32.25
Vol. 6.68M
Mkt cap 13.19B
P/E 27.78
EPS 1.17
Shares 394.34M

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 8.21% 7.47%
Operating margin 8.98% 8.24%
EBITD margin - 9.34%
Return on average assets 10.34% 9.61%
Return on average equity 17.11% 15.01%
Employees 3,292 -
CDP Score - -


No. 166 Keyi Road, High-tech Development Zone
+86-871-68324311 (Phone)
+86-871-68324267 (Fax)

Website links


KPC Pharmaceuticals, Inc., formerly Kunming Pharmaceutical Corp., is a China-based company principally engaged in manufacture, wholesaling and retailing of pharmaceuticals. The Company provides natural herbal medicines and chemical compound drugs, including drugs for central nervous systems, drugs for cardio and cerebral vascular diseases, anti-parasite drugs, antimicrobial drugs, anti-gout drugs, hormones and endocrine regulation drugs, drugs for hemorrhoids and anti-inflammatory drugs, among others. The Company also involves in pharmaceutical purchasing and distribution, as well as health supplements manufacturing. It distributes its products in domestic and overseas markets.

Officers and directors

Qin He Chairman of the Board
Age: 53
Xiaochang Dai President
Age: 52
Jiahong Lin Vice Chairman of the Board
Age: 45
Shaoquan Wang Chief Financial Officer
Age: 45
Chaoneng Xu Vice President, Secretary of the Board
Age: 49
Shaoyu Dong Vice President
Age: 56
Zhongzhan Lin Vice President
Age: 44
Peng Liu Vice President
Age: 49
Rong Pei Director
Age: 42
Siyang Wang Director
Age: 26